Aldagen is a company headquartered in the United States.
Aldagen develops regenerative cell therapies aimed at repairing and restoring damaged tissues, focusing on hematopoietic stem cell transplantation and immune system recovery.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.